Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02224625Phase 3Completed
Phase 3, randomised, single-blind trial of chlorhexidine in surgical site infection (SSI) (4 arms), sponsored by Medline. Primary endpoint: Grading Scale for Visual Evaluation of Skin Condition at 35 days. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02224625.